Dubravka Smiljkovic Selected Research

Dubravka Smiljkovic Research Topics

3	Systemic Mastocytosis 01/2023 - 12/2015
2	Hypersensitivity (Allergy) 01/2023 - 01/2020
2	Mastocytosis 01/2022 - 01/2020
2	Leukemia 12/2021 - 11/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2019
1	Dyspnea (Shortness of Breath) 03/2017
1	Asthma (Bronchial Asthma) 03/2017
1	Hodgkin Disease (Hodgkin's Disease) 12/2015
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2015

2	avapritinibIBA 01/2023 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2020 - 03/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Surface Antigens (Surface Antigen)IBA 01/2023
1	nintedanibIBA 01/2023
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2021
1	venetoclaxIBA 12/2021
1	Azacitidine (5 Azacytidine)FDA Link 12/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2021
1	AllergensIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	ibrutinibIBA 12/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Histamine Antagonists (Antihistamines)IBA 03/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2017
1	IgE Receptors (Fc epsilon RI)IBA 03/2017
1	anti-IgE antibodiesIBA 03/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2017
1	Omalizumab (Xolair)FDA Link 03/2017
1	Ki-1 AntigenIBA 12/2015

1	Immunotherapy 11/2020
1	Drug Therapy (Chemotherapy) 11/2020
1	Blood Component Removal (Apheresis) 03/2017